Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hidden biases in an observational study of bevacizumab beyond progression.

× No keyword cloud information.

5 in total

1. APOBEC3G expression is correlated with poor prognosis in colon carcinoma patients with hepatic metastasis.

Authors: Huanrong Lan; Ketao Jin; Meifu Gan; Shouxiang Wen; Tienan Bi; Shenkang Zhou; Naibiao Zhu; Lisong Teng; Wenjie Yu
Journal: Int J Clin Exp Med Date: 2014-03-15

Review 2. [Current medicinal treatment of metastasized colorectal carcinoma].

Authors: G Folprecht
Journal: Chirurg Date: 2010-06 Impact factor: 0.955

3. Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice.

Authors: Gregory P Hess; Peter Feng Wang; David Quach; Beth Barber; Zhongyun Zhao
Journal: J Oncol Pract Date: 2010-11 Impact factor: 3.840

4. Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy.

Authors: Yong Sang Hong; Jeeyun Lee; Kyu-pyo Kim; Jae-Lyun Lee; Young Suk Park; Joon Oh Park; Se Hoon Park; Sun Young Kim; Ji Yeon Baek; Jee Hyun Kim; Keun-Wook Lee; Tae-You Kim; Tae Won Kim
Journal: Invest New Drugs Date: 2012-07-11 Impact factor: 3.850

Review 5. Treatment in advanced colorectal cancer: what, when and how?

Authors: I Chau; D Cunningham
Journal: Br J Cancer Date: 2009-05-12 Impact factor: 7.640

5 in total